Medline Inc. income statement & cash flow

Ticker MDLN · SEC CIK 2046386 · Latest fiscal year ended Dec 31, 2025

In the fiscal year ended Dec 31, 2025, Medline Inc. reported net income of $1.16B on revenue of $28.43B. Operating cash flow was $1.74B and capital expenditures were $447.00M, leaving $1.30B of free cash flow (operating cash flow minus capital expenditures).

Medline Inc. net income by fiscal year, USD. Hover a bar for the exact figure.

Income statement and cash flow summary

Fiscal year ended	Dec 2023	Dec 2024	Dec 2025	Dec 2025
Revenue (USD)	$23.23B	$25.51B	—	$28.43B
Gross profit (USD)	$5.88B	$6.98B	—	$7.52B
Operating income (USD)	$1.25B	$2.15B	—	$2.21B
Net income (USD)	$234.00M	$1.16B	$1.15B	$1.16B
Diluted EPS (USD per share)	—	—	—	−$0.01
Operating cash flow (USD)	$1.69B	$1.77B	—	$1.74B
Capital expenditures (USD)	$275.00M	$354.00M	—	$447.00M
Reported in	10-K 2026	10-K 2026	10-K 2026	10-K 2026

Columns are fiscal years, labeled by the month the year ended; scroll sideways on small screens. — means the company did not report the figure under the XBRL concepts we track.

Margins

Each figure divided by revenue for the same fiscal year.

Fiscal year ended	Gross margin	Operating margin	Net margin
Dec 2025	26.4%	7.8%	4.1%
Dec 2024	27.3%	8.4%	4.6%
Dec 2023	25.3%	5.4%	1.0%

Medline Inc. operating cash flow by fiscal year, USD. Hover a bar for the exact figure.

Source: SEC EDGAR XBRL company facts for CIK 2046386 (raw data). Most recent filing in this dataset: 10-Q filed Aug 5, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.